The inhibitory effect of an EGF receptor-specific tyrosine kinase inhibitor on pancreatic cancer cell lines was more potent than inhibitory antibodies against the receptors for EGF and IGF I
International journal of pancreatology · 1998-10 · 24 (2) · 85-95
DOI: 10.1007/bf02788565 ↗Kurz gefasst
Fachartikel in der Zeitschrift International journal of pancreatology, 1998-10. Verfasst von M Kobari und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgery, University Hospital, Lund, Sweden. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 37 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Surgery, University Hospital, Lund, Sweden.
Zitieren
APA
Kobari, M., Kullenberg, B., Björkman, A., Matsuno, S., Ihse, I., & Axelson, J. (1998). The inhibitory effect of an EGF receptor-specific tyrosine kinase inhibitor on pancreatic cancer cell lines was more potent than inhibitory antibodies against the receptors for EGF and IGF I. International journal of pancreatology, 24(2), 85-95. https://doi.org/10.1007/bf02788565
Vancouver
Kobari M, Kullenberg B, Björkman A, Matsuno S, Ihse I, Axelson J. The inhibitory effect of an EGF receptor-specific tyrosine kinase inhibitor on pancreatic cancer cell lines was more potent than inhibitory antibodies against the receptors for EGF and IGF I. International journal of pancreatology. 1998;24(2):85-95. doi:10.1007/bf02788565
BibTeX
@article{Kobari1998,
author = {Kobari, M and Kullenberg, B and Björkman, A and Matsuno, S and Ihse, I and Axelson, J},
title = {The inhibitory effect of an EGF receptor-specific tyrosine kinase inhibitor on pancreatic cancer cell lines was more potent than inhibitory antibodies against the receptors for EGF and IGF I},
journal = {International journal of pancreatology},
year = {1998},
volume = {24},
number = {2},
pages = {85--95},
doi = {10.1007/bf02788565}
}
EUVIMED